These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29436791)

  • 41. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
    Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O
    PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
    Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
    Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
    McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
    BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
    Park HW; Kang HC; Kim IJ; Jang SG; Kim K; Yoon HJ; Jeong SY; Park JG
    Int J Cancer; 2007 Jan; 120(1):7-12. PubMed ID: 17013898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promoter hypermethylation of membrane type 3 matrix metalloproteinase is associated with cell migration in colorectal adenocarcinoma.
    Moon JW; Choi JH; Lee SK; Lee YW; Lee JO; Kim N; Lee HJ; Seo JS; Kim J; Kim HS; Kim GJ; Park SH
    Cancer Genet; 2015 May; 208(5):261-70. PubMed ID: 26002729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significant Pattern of Promoter Hypermethylation of UNC5C Gene in Colorectal Cancer and Its Implication in Late Stage Disease.
    Guroo SA; Malik AA; Afroze D; Ali S; Pandith AA; Yusuf A
    Asian Pac J Cancer Prev; 2018 May; 19(5):1185-1188. PubMed ID: 29801399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylation status of ADAM12 promoter are associated with its expression levels in colorectal cancer.
    Wang Y; Zhang J; Cao H; Han F; Zhang H; Xu E
    Pathol Res Pract; 2021 May; 221():153449. PubMed ID: 33930608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microsatellite instability and promoter hypermethylation of MLH1 and MSH2 in patients with sporadic colorectal cancer.
    Vlaykova T; Mitkova A; Stancheva G; Kadiyska T; Gulubova M; Yovchev Y; Cirovski G; Chilingirov P; Damyanov D; Kremensky I; Mitev V; Kaneva R
    J BUON; 2011; 16(2):265-73. PubMed ID: 21766496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer.
    Riojas MA; Guo M; Glöckner SC; Machida EO; Baylin SB; Ahuja N
    Cancer Biol Ther; 2007 Nov; 6(11):1710-6. PubMed ID: 17986858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy.
    Chang SY; Kuo CC; Wu CC; Hsiao CW; Hu JM; Hsu CH; Chou YC; Shih YL; Lin YW
    Genes Chromosomes Cancer; 2018 May; 57(5):268-277. PubMed ID: 29363224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
    Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
    Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.
    Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M
    J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review.
    Liang TJ; Wang HX; Zheng YY; Cao YQ; Wu X; Zhou X; Dong SX
    Oncotarget; 2017 Jul; 8(28):46468-46479. PubMed ID: 28515349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran.
    Yari K; Payandeh M; Rahimi Z
    Tumour Biol; 2016 Jun; 37(6):8145-52. PubMed ID: 26715274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients.
    Chen SQ; Chen ZH; Lin SY; Dai QB; Fu LX; Chen RQ
    World J Gastroenterol; 2014 Aug; 20(29):10071-81. PubMed ID: 25110434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.
    Azuara D; Aussó S; Rodriguez-Moranta F; Guardiola J; Sanjuan X; Lobaton T; Boadas J; Piqueras M; Monfort D; Guinó E; Moreno V; Capellá G; de Oca J
    Inflamm Bowel Dis; 2018 Nov; 24(12):2555-2564. PubMed ID: 30099509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
    Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Colon-Specific DNA Methylation-Regulated Gene Modules on Colorectal Cancer Patient Survival.
    Yu H; Jiang W; Chen G; Yang F; Zhao X; Ji Z; Ni J; Fu Y; Chen F; Zhao B
    Med Sci Monit; 2019 May; 25():3549-3557. PubMed ID: 31083646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.